pharmaceutical investing BioSyent Named as One of Canada's Top Growing Companies 2026 by The Globe and Mail
pharmaceutical investing BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference
pharmaceutical investing BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026
Equity Metals Reports Assays from 2026 Validation Drilling on the No. 3 Vein and Active Q4 Exploration Initiatives, Silver Queen Project, BC
